{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:50:17Z","timestamp":1787982617377,"version":"build-2784847793"},"reference-count":23,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"SANOFI Pasteur","doi-asserted-by":"publisher","award":["PER00081"],"award-info":[{"award-number":["PER00081"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.1080\/21645515.2021.1965424","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:58:35Z","timestamp":1631131115000},"page":"4225-4234","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["How were DTP-related adverse events reduced after the introduction of an acellular pertussis vaccine in Chile?"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6430-1417","authenticated-orcid":false,"given":"Francisca","family":"Aguirre-Boza","sequence":"first","affiliation":[{"name":"Vicedecanato de Investigaci\u00f3n. Facultad de Medicina, Universidad de Los Andes, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1974-3050","authenticated-orcid":false,"given":"Pamela","family":"San Mart\u00edn P","sequence":"additional","affiliation":[{"name":"Vicedecanato de Investigaci\u00f3n. Facultad de Medicina, Universidad de Los Andes, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Teresa","family":"Valenzuela B","sequence":"additional","affiliation":[{"name":"Vicedecanato de Investigaci\u00f3n. Facultad de Medicina, Universidad de Los Andes, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"World Health Organization Global Vaccine Safety. AEFI detection. Geneva (Switzerland): WHO; 2020 [accessed 2021 January 10]. Available from: https:\/\/www.who.int\/vaccine_safety\/initiative\/detection\/en\/."},{"key":"e_1_3_3_3_1","volume-title":"CH E2E Pharmacovigilance planning (Pvp)","author":"European Medicines Agency","year":"2004","unstructured":"European Medicines Agency. CH E2E Pharmacovigilance planning (Pvp). European Medicines Agency; 2004."},{"key":"e_1_3_3_4_1","first-page":"193","volume-title":"Definition and application of terms for vaccine pharmacovigilance","author":"CIOMS\/WHO Working Group on Vaccine Pharmacovigilance","year":"2012","unstructured":"CIOMS\/WHO Working Group on Vaccine Pharmacovigilance. Definition and application of terms for vaccine pharmacovigilance. CIOMS\/WHO, editor. Geneva; 2012. p. 193."},{"key":"e_1_3_3_5_1","unstructured":"World Health Organization Global Vaccine Safety. Core variables for AEFI Switzerland: WHO; 2020 [accessed 2021 January 10] https:\/\/www.who.int\/vaccine_safety\/news\/HL_1\/en\/."},{"key":"e_1_3_3_8_1","volume-title":"Departamento Agencia Nacional de Medicamentos Instructivo Para La Notificaci\u00f3n De Sospechas De Reacciones Adversas A Medicamentos 2020","author":"ISP","year":"2020","unstructured":"Departamento Agencia Nacional de Medicamentos Instructivo Para La Notificaci\u00f3n De Sospechas De Reacciones Adversas A Medicamentos 2020. ISP, editor; 2020."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.4067\/S0716-10182019000400461"},{"key":"e_1_3_3_10_1","unstructured":"Departamento de estad\u00edsticas e Informaci\u00f3n de Salud Ministerio de Salud. Gobierno de Chile Cobertura de vacunaci\u00f3n program\u00e1tica: departamento de estad\u00edsticas e Informaci\u00f3n de Salud. Ministerio de Salud. Gobierno de Chile; 2020 [accessed 2020 July 20] http:\/\/www.deis.cl\/estadisticas-inmunizaciones\/."},{"key":"e_1_3_3_11_1","volume-title":"Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification. Second ed. Geneva; 2018."},{"key":"e_1_3_3_12_1","volume-title":"Subsecreatar\u00eda de Salud P\u00fablica. Decreto 7 Aprueba el Reglamento sobre Notificaci\u00f3n de Enfermedades Transmisibles de Declaracion Obligatoria y su Vigilancia","author":"Ministerio de Salud","year":"2019","unstructured":"Ministerio de Salud. Subsecreatar\u00eda de Salud P\u00fablica. Decreto 7 Aprueba el Reglamento sobre Notificaci\u00f3n de Enfermedades Transmisibles de Declaracion Obligatoria y su Vigilancia; 2019."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1800458"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws167"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1549449"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/2515135519889000"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002109"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.08.068"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.26719\/2018.24.2.119"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15061149"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.106.4.e52"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1048937"},{"key":"e_1_3_3_24_1","first-page":"142","article-title":"Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines","volume":"1","author":"Moro P","year":"2018","unstructured":"Moro P, Perez-Vilar S, Lewis P, Bryant-Genevier M, Kamiya H, Cano M. Safety surveillance of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccines. Pediatrics. 2018;1:142.","journal-title":"Pediatrics"},{"key":"e_1_3_3_25_1","volume-title":"Supplementary information on vaccine safety. Part 2 background rates of adverse events following immunization","author":"Department of Vaccines and Biologicals","year":"2000","unstructured":"Department of Vaccines and Biologicals. Supplementary information on vaccine safety. Part 2 background rates of adverse events following immunization. WHO, editor; 2000."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3757"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0150-2"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1965424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:52:48Z","timestamp":1709304768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1965424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,2]]}},"alternative-id":["10.1080\/21645515.2021.1965424"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1965424","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}